Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Post by 1ottrunneron Feb 09, 2022 9:15am
99 Views
Post# 34411736

Hopefully no stop losses at .265

Hopefully no stop losses at .265

There are 200k shares depth to the very bottom right now and a few big stop losses could get this under 20 cents in a hurry.

MF better have a rabbit to pull soon. The smoke, the mirrors, they didn't work.

It's great that investor interview a prof to clarify trial procedure. Some clarity though, notice how the fine prof comments that trials in different zones often compete against one another.

The trial has not been updated to include Turkey data, thus, a new trial may have been initiated in Turkey and has not yet been posted to the clinical trial site.

The data may not be incorporated in the trial currently underway.

MF should clarify

<< Previous
Bullboard Posts
Next >>